SCHEMBL4018186

SCHEMBL4018186

Cc1cc(-c2cnc(N)nc2C)on1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
PIK3R1 P27986 1/20 0.40
PIK3CA P42336 1/20 0.40
MTOR P42345 1/20 0.40
PIK3CD O00329 6/20 0.40
PIK3CG P48736 6/20 0.40
PIK3CB P42338 4/20 0.40
PRKAB2 O43741 6/20 0.39
PRKAG1 P54619 6/20 0.39
PRKAA2 P54646 6/20 0.39
PRKAA1 Q13131 6/20 0.39
PRKAG3 Q9UGI9 6/20 0.39
PRKAG2 Q9UGJ0 6/20 0.39
PRKAB1 Q9Y478 6/20 0.39
BRD4 O60885 1/20 0.38
TMEM97 Q5BJF2 3/20 0.37
SIGMAR1 Q99720 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24348363 0.81 PRKAB2 (0.38) KDM4EUSP2ALDH1A1TSHRPIK3CD
SCHEMBL24349466 0.80 PIK3CB (0.42) KDM4EPIK3R1PIK3CAMTORPIK3CD
SCHEMBL24348936 0.77 PRKAB2 (0.63) KDM4EUSP2ALDH1A1TSHRPIK3CD
SCHEMBL10262356 0.72 KDM4E (0.46) KDM4EUSP2ALDH1A1TSHRPIK3CD
SCHEMBL11034614 0.72 ABL1 (0.42) PIK3R1PIK3CAMTORKMT2A
SCHEMBL4012820 0.71 IMPDH2 (0.42) PIK3R1PIK3CAMTOR
SCHEMBL24349472 0.70 PRKAB2 (0.69) KDM4EUSP2PRKAB2PRKAG1PRKAA2
SCHEMBL17203223 0.69 PIK3CD (0.50) PIK3CAMTORPIK3CDPIK3CGPIK3CB
SCHEMBL14927235 0.68 PIK3CG (0.43) PIK3R1PIK3CAMTORPIK3CDPIK3CG
SCHEMBL15659764 0.68 ILK (0.43) KDM4EUSP2ALDH1A1TSHRPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044063-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Astra Zeneca AB (SE) 2009-04-08 EP disclosed
WO-2008001070-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-01-03 WO disclosed